Your browser doesn't support javascript.
loading
Knockdown of PRKD2 Enhances Chemotherapy Sensitivity in Cervical Cancer via the TP53/CDKN1A Pathway.
Feng, Ruijing; Wang, Xin; Chen, Hongwei; Cao, Chen; Liu, Ting; Zhao, Tong; Chen, Huang; Tian, Rui; Ni, Yangyang; Tian, Xun; Hu, Zheng; Ma, Ji; Gong, Danni.
Afiliação
  • Feng R; Department of Obstetrics and Gynecology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, Hubei, China.
  • Wang X; Department of Obstetrics and Gynecology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, Hubei, China.
  • Chen H; Department of Obstetrics and Gynecology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, Hubei, China.
  • Cao C; Department of Obstetrics and Gynecology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, Hubei, China.
  • Liu T; Department of Obstetrics and Gynecology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, Hubei, China.
  • Zhao T; Department of Obstetrics and Gynecology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, Hubei, China.
  • Chen H; Department of Obstetrics and Gynecology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, Hubei, China.
  • Tian R; School of Medicine, Jianghan University, Wuhan 430056, Hubei, China.
  • Ni Y; Center for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong, China.
  • Tian X; Sun Yat-sen University Nanchang Research Institution, Nanchang 330200, Jiangxi, China.
  • Hu Z; Department of Obstetrics and Gynecology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, Hubei, China.
  • Ma J; School of Medicine, Jianghan University, Wuhan 430056, Hubei, China.
  • Gong D; Department of Obstetrics and Gynecology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, Hubei, China.
Curr Cancer Drug Targets ; 23(2): 159-170, 2023.
Article em En | MEDLINE | ID: mdl-36017858
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Proteína Supressora de Tumor p53 / Inibidor de Quinase Dependente de Ciclina p21 / Proteína Quinase D2 Tipo de estudo: Diagnostic_studies Limite: Female / Humans Idioma: En Revista: Curr Cancer Drug Targets Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Proteína Supressora de Tumor p53 / Inibidor de Quinase Dependente de Ciclina p21 / Proteína Quinase D2 Tipo de estudo: Diagnostic_studies Limite: Female / Humans Idioma: En Revista: Curr Cancer Drug Targets Ano de publicação: 2023 Tipo de documento: Article